ALK peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-009774
A peptide cancer vaccine directed against the receptor tyrosine kinase anaplastic lymphoma kinase (ALK), with potential immunostimulatory and antineoplastic activities. Upon administration, ALK peptide vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against ALK-expressing tumor cells. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.
| Identifier | MLC-T-ONC-009774 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009774",
"term": "ALK peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A peptide cancer vaccine directed against the receptor tyrosine kinase anaplastic lymphoma kinase (ALK), with potential immunostimulatory and antineoplastic activities. Upon administration, ALK peptide vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against ALK-expressing tumor cells. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alk-peptide-vaccine/"
}
Record 643 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.